Table 5.
Scaffold composition | Antimicrobial agent | Fabrication technique | Results | References | |
---|---|---|---|---|---|
Antimicrobial metallic NPs embedded in the scaffold | β-tricalcium phosphate bioceramic scaffolds modified with silver NPs-graphene oxide nanocomposite | AgNPs | 3D printing followed by a soaking method | In vitro antibacterial activity against E. coli
In vitro osteogenic differentiation and proliferation of rabbit bone marrow stromal cells cultured in the scaffolds |
[125] |
MgSrFe-layered double hydroxide/chitosan composite scaffold loaded with uniformly dispersed Ag NPs on the scaffold surfaces | AgNPs | Freeze-drying preparation of the precursor scaffold followed by deposition of AgNPs on the MgSrFe/CS composite | In vitro antibacterial activity against S. aureus biofilm | [126] | |
In vitro osteogenetic differentiation of human bone marrow-derived mesenchymal stem cells cultured in the scaffolds | |||||
Scaffolds containing chitosan and carboxymethyl cellulose decorated with AgNPs | AgNPs and chitosan | Freeze-drying method | In vitro antibacterial activity against E. coli and Enterococcus hirae (E. hirae) | [127] | |
Chitosan, HA, and silver nanowires composite scaffold | Silver nanowires and chitosan | Freeze drying of the thermosensitive hydrogels after sol–gel transition | In vitro antibacterial activity against E. coli and S. aureus, methicillin-resistant S. aureus and S. saprophyticus | [128] | |
Porous titanium scaffold possessing a micro/nanostructured titanate layer and provided with nanosilver encapsulated in physically cross-linked silk fibrin | Nanosilver | Metallic powder 3D printing followed by in situ hydrothermal growth of a metal oxide and cross-linking of silk fibrin to physically encapsulate nanosilver | In vitro antibacterial activity against clinically relevant pathogenic S. aureus bacteria biofilm | [129] | |
Zinc oxide NPs nanocrystalline HA scaffolds coated by gelatine | ZnO NPs | Space holder technique | In vitro | [130] | |
Cu NPs on carboxymethyl chitosan and alginate | CuNPs | Cross-linking of the polymer mixtures followed by freeze drying | In vivo rat ectopic osteogenesis and infection model inoculated with S. aureus clinically collected S. aureus | [131] | |
Antibiotic-loaded NPs embedded in the scaffold | MSNs/gelatin matrix composite scaffold | Vancomycin-loaded MSNs | Freeze-drying method | In vitro antibacterial activity against S. aureus | [133] |
MSNs immobilized on the surface of a nanoHA/polyurethane bioactive composite scaffold | Levofloxacin-loaded MSNs | Immobilization of the MSNs by pretreatment of scaffold with chitosan and subsequent cross-linking by vanillin | In vitro antibacterial activity against E. coli and S. aureus | [134] | |
ZIF8 nanocrystals (metal-organic frameworks) embedded in chitosan scaffolds | Vancomycin-loaded ZIF8 | Wet spinning | In vitro antibacterial activity against S. aureus | [135] | |
BMP2 encapsulated into gelatin microspheres and vancomycin encapsulated into gelatin microspheres drug-contained gelatin microspheres assembled on GO-functionalized Ti porous scaffold | Vancomycin encapsulated into gelatin microspheres | Deposition of GO nanosheets onto mussel-inspired polydopamine-modified Ti scaffolds prepared via a powder sintering method | In vitro antibacterial activity against S. epidermidis
In vivo ectopic bone regeneration in subcutaneous rat model to assess bone regeneration ability of the scaffolds |
[136] | |
Incorporation of NPs in the scaffold for a dual effect | Chitosan/nanoHA scaffold doped with OD carbon dots | Chitosan combined with the photothermal effect of carbon dots | Physical mixing and freeze-drying method | In vitro antibacterial activity against clinically relevant S. aureus and E. coli
In vivo model in muscle pouches of rats inoculated with clinically collected S. aureus and E. coli |
[139] |
Nanostructured magnetic Mg2SiO4-CoFe2O4 composite scaffold | Rifampin combined with the magnetic hyperthermia effect | Polymer sponge and sintering technique to fabricate 3D porous scaffolds from Mg2SiO4-CoFe2O4 nanocomposite | In vitro antibacterial activity against S. aureus | [140] | |
Silk fibroin NPs loaded with vascular endothelial growth factor embedded in a silk scaffold containing vancomycin | Vancomycin combined with the delivery of angiogenic factors | Freeze drying followed by cross-linking | In vitro antibacterial against methicillin-resistant S. aureus (MRSA) | [141] |